Bridging the Gap: From Ophthalmic Drug Delivery Research to Commercial Viability
Successful commercialization of novel ophthalmic drug delivery systems requires close collaboration between academic researchers and industry stakeholders to translate laboratory advancements into viable clinical products.
Investigative Ophthalmology & Visual Science · 2010
Key Findings
- 01A diverse group of over 200 experts from academic ophthalmology and the ophthalmic pharmaceutical industry convened.
- 02The focus was on recent advances in delivery systems for ocular drugs targeting the posterior segment.
- 03Discussion centered on the successful translation of these systems into commercial products.
Application
Design takeaway
Designers and researchers must actively seek opportunities for cross-sector collaboration and consider market feasibility and regulatory requirements from the outset of their design projects.
How to apply
When developing new medical technologies, proactively identify and engage with potential industry partners and regulatory consultants to understand market demands and compliance requirements.
Project actions
- 01Consider who the end-users and commercial stakeholders are for your design.
- 02Research existing market trends and regulatory hurdles for similar products.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Involves a large and diverse group of experts.
- +Addresses a critical stage in the innovation pipeline: commercialization.
Limitations
The conference focused on a specific area of medicine, so the findings might not apply to all product development scenarios.
Reliability & validity
The reliability and validity of the findings are based on the collective expertise and consensus of a large group of specialists, suggesting a strong degree of face validity and expert opinion support.
Think critically
How might the differing priorities of academic researchers (e.g., scientific discovery) and industry professionals (e.g., profitability, market share) create friction in the commercialization process, and how can design effectively mediate these differences?
Design Principles
"Integrate market and stakeholder analysis throughout the design process to ensure research translates into impactful commercial solutions."
This insight highlights the critical need for interdisciplinary communication and strategic partnerships in the design and development process. Understanding the commercial landscape and regulatory pathways early on can significantly de-risk innovation and accelerate the adoption of new therapeutic solutions.
What This Means for Your Design
To make new eye medicines that reach the back of the eye successful, scientists and companies need to work together to turn lab ideas into products people can actually buy and use.
How to use in your project
- 1.Reference this study when discussing the importance of industry-academia collaboration in your design project's development and evaluation.
Add to My Project
Quick Cite
(2010). Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.10-5392 Retrieved from https://designdex.org/study/b84f3b09-8bd0-46c9-9375-eb06165be855/bridging-the-gap-from-ophthalmic-drug-delivery-research-to-commercial-viability
Paragraph starter
The successful translation of advanced ophthalmic drug delivery systems from basic research to clinical application necessitates a strong collaborative bridge between academic innovation and industry expertise, as highlighted by expert consensus on the need for integrated development strategies to navigate commercialization pathways.
Source
Investigative Ophthalmology & Visual Science
Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications
journal · 2010
View sourceQuestions about this research
- What does the research say about bridging the gap: from ophthalmic drug delivery research to commercial viability?
- Designers and researchers must actively seek opportunities for cross-sector collaboration and consider market feasibility and regulatory requirements from the outset of their design projects. Evidence: Investigative Ophthalmology & Visual Science (2010).
- Why does "Bridging the Gap: From Ophthalmic Drug Delivery Research to Commercial Viability" matter for design?
- This insight highlights the critical need for interdisciplinary communication and strategic partnerships in the design and development process. Understanding the commercial landscape and regulatory pathways early on can significantly de-risk innovation and accelerate the adoption of new therapeutic solutions.
- How can designers apply this research?
- Designers and researchers must actively seek opportunities for cross-sector collaboration and consider market feasibility and regulatory requirements from the outset of their design projects.
- What were the main findings?
- A diverse group of over 200 experts from academic ophthalmology and the ophthalmic pharmaceutical industry convened.. The focus was on recent advances in delivery systems for ocular drugs targeting the posterior segment.. Discussion centered on the successful translation of these systems into commercial products.
- What research method was used?
- Expert consensus and review with 200+ participants.
- How strong is the evidence?
- Evidence strength is rated Strong effect, based on a 2010 journal from Investigative Ophthalmology & Visual Science.
- What should I do differently in my next project?
- When developing new medical technologies, proactively identify and engage with potential industry partners and regulatory consultants to understand market demands and compliance requirements.
- What are the limitations?
- The findings represent a snapshot of expert opinion at a specific conference and may not capture all nuances of the commercialization process.
- Is there evidence that ophthalmic drug affects design outcomes?
- A large gathering of academic and industry experts identified the need for collaboration to move advanced ophthalmic drug delivery research from the lab to the market. This insight highlights the critical need for interdisciplinary communication and strategic partnerships in the design and development process. Understa Source: Investigative Ophthalmology & Visual Science (2010).
- Where does this drug delivery research apply?
- Ophthalmic drug delivery systems for retinal diseases It sits within innovation & markets research on designdex.org.
Related research topics
ophthalmic drug design research · evidence on ophthalmic drug · does ophthalmic drug improve design outcomes · drug delivery studies for designers · ophthalmic drug and drug delivery findings · innovation & markets research evidence